Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - October 2011

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Adrenaline tartrate pre-filled pens (Jext®) have been accepted for the emergency treatment of severe acute allergic reactions. It is noted that this product has a longer shelf life compared to existing products.

Bromfenac eye drops (Yellox®) have been rejected for the treatment of postoperative ocular inflammation following cataract extraction in adults. The manufacturer failed to make a submission.

Fluorouracil and salicylic acid solution (Actikerall®) has been accepted for the topical treatment of grade I or II hyperkeratotic actinic keratosis in immunocompetent adult patients.

Olmesartan / amlodipine / hydrochlorothiazide tablets (Sevikar HCT®) has been accepted as a substitution therapy in adult patients whose blood pressure is adequately controlled on these three agents in different formulations.

Quetiapine modified release tablets (Seroquel XL®) have been rejected as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD). The manufacturer failed to make a submission.

Rosuvastatin tablets (Crestor®) have been rejected for the prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event. The manufacturer failed to present a sufficiently robust economic analysis to gain acceptance.

Vardenafil orodispersible tablets (Levitra®) have been accepted for restricted use in the treatment of erectile dysfunction (ED) in adult men in whom an orodispersible tablet is an appropriate formulation.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - October 2011' on Email Share 'SMC Update - October 2011' on Delicious Share 'SMC Update - October 2011' on Digg Share 'SMC Update - October 2011' on Facebook Share 'SMC Update - October 2011' on Google+ Share 'SMC Update - October 2011' on reddit Share 'SMC Update - October 2011' on StumbleUpon Share 'SMC Update - October 2011' on Twitter

atomic-wealth

No Comments to “SMC Update - October 2011”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer